BC Week In Review | Apr 15, 2013
Clinical News

BC Sera Dx: Phase II data

A Russian Phase II trial showed that OTraces' BC Sera Dx blood test was 98% accurate for detecting breast cancer in women. The company could not be reached for details or next steps. OTraces Inc....
Items per page:
1 - 1 of 1